{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:31:45Z","timestamp":1772566305019,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1053\/j.semdp.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:51:29Z","timestamp":1616784689000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Update on B-cell lymphoproliferative disorders of the gastrointestinal tract"],"prefix":"10.1053","volume":"38","author":[{"given":"Regina M.","family":"Plummer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy K.","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0001","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000658-196908000-00011","article-title":"Primary lymphoma of the gastrointestinal tract","volume":"170","author":"Loehr","year":"1969","journal-title":"Ann Surg"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0002","first-page":"108","article-title":"Lymphosarcoma of the gastro-intestinal tractreport of twenty cases","volume":"119","author":"McSwain","year":"1944","journal-title":"Ann Surg"},{"issue":"11","key":"10.1053\/j.semdp.2021.03.006_bib0003","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1440-1827.2002.01403.x","article-title":"Clinicopathological features of gastric B-cell lymphoma: a series of 317 cases","volume":"52","author":"Hatano","year":"2002","journal-title":"Pathol Int"},{"issue":"18","key":"10.1053\/j.semdp.2021.03.006_bib0004","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1200\/JCO.2001.19.18.3861","article-title":"Primary Gastrointestinal Non-Hodgkin's Lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the german multicenter study GIT NHL 01\/92","volume":"19","author":"Koch","year":"2001","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/1471-2407-11-321","article-title":"Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Cancer"},{"issue":"01","key":"10.1053\/j.semdp.2021.03.006_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/ojbd.2020.101001","article-title":"Diagnostic utility of performing flow cytometry on provider-submitted endoscopically collected gastrointestinal samples","volume":"10","author":"Plummer","year":"2020","journal-title":"Open J Blood Dis"},{"key":"10.1053\/j.semdp.2021.03.006_bib0007","series-title":"Odze and Goldblum Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas","first-page":"846","article-title":"Hematolymphoid tumors of the Gastrointestinal Tract, Hepatobiliary Tract, and Pancreas","author":"Ferry","year":"2015"},{"issue":"6 Part A","key":"10.1053\/j.semdp.2021.03.006_bib0008","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.semcancer.2013.09.001","article-title":"B-cell receptor signaling as a driver of lymphoma development and evolution","volume":"23","author":"Niemann","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semdp.2021.03.006_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.604685","article-title":"Role of Specific B-cell receptor antigens in lymphomagenesis","volume":"10","author":"Thurner","year":"2020","journal-title":"Front Oncol"},{"issue":"6","key":"10.1053\/j.semdp.2021.03.006_bib0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ajcp\/aqy077","article-title":"Diagnosis of lymphoid lesions in limited samples","volume":"150","author":"Mesa","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2021.03.006_bib0011","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.humpath.2013.12.001","article-title":"The recognition and classification of lymphoproliferative disorders of the gut","volume":"45","author":"O'Malley","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2021.03.006_bib0012","unstructured":"Swerdlow S., Campo E., Harris N., et\u00a0al. WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. In: Revised 4t IARC; 2017."},{"issue":"3\u20134","key":"10.1053\/j.semdp.2021.03.006_bib0013","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12308-017-0302-2","article-title":"Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma","volume":"10","author":"Schreuder","year":"2017","journal-title":"J Hematop"},{"issue":"36","key":"10.1053\/j.semdp.2021.03.006_bib0014","doi-asserted-by":"crossref","first-page":"12993","DOI":"10.3748\/wjg.v20.i36.12993","article-title":"Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up","volume":"20","author":"Vetro","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"8871","key":"10.1053\/j.semdp.2021.03.006_bib0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0016","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/annonc\/mdp402","article-title":"Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas","volume":"21","author":"Luminari","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2021.03.006_bib0017","doi-asserted-by":"crossref","first-page":"491","DOI":"10.12659\/AJCR.902843","article-title":"Mucosa-associated lymphoid tissue (MALT) lymphoma of the colon: a case report and a literature review","volume":"18","author":"Abbas","year":"2017","journal-title":"Am J Case Rep"},{"issue":"3","key":"10.1053\/j.semdp.2021.03.006_bib0018","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp038200","article-title":"Bacterial Infection and MALT Lymphoma","volume":"350","author":"Parsonnet","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.semdp.2021.03.006_bib0019","first-page":"1139","article-title":"\u03b1-Heavy chain disease, mediterranean lymphoma, and immunoproliferative small intestinal disease","volume":"94","author":"Fine","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0020","doi-asserted-by":"crossref","DOI":"10.5858\/arpa.2016-0610-RA","article-title":"Lymphoproliferative disorders of the gastrointestinal tract","volume":"142","author":"Skinnider","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0021","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.12596","article-title":"Recent advances in intestinal lymphomas","volume":"66","author":"Foukas","year":"2015","journal-title":"Histopathology"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0022","doi-asserted-by":"crossref","first-page":"542","DOI":"10.5858\/arpa.2016-0519-RS","article-title":"Duodenal-type follicular lymphoma a clinicopathologic review","volume":"142","author":"Marks","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1053\/j.semdp.2021.03.006_bib0023","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3748\/wjg.v17.i6.697","article-title":"Primary gastrointestinal lymphoma","volume":"17","author":"Ghimire","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1053\/j.semdp.2021.03.006_bib0024","first-page":"599","article-title":"Endoscopic findings in chronic lymphocytic leukemia","volume":"23","author":"Gon\u00e7alves","year":"2000","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1053\/j.semdp.2021.03.006_bib0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.humpath.2016.09.011","article-title":"Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma","volume":"59","author":"Ikeda","year":"2017","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2021.03.006_bib0026","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.humpath.2014.04.004","article-title":"Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma","volume":"45","author":"Metcalf","year":"2014","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2021.03.006_bib0027","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/modpathol.2017.58","article-title":"Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms","volume":"30","author":"Onaindia","year":"2017","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2021.03.006_bib0028","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.24797","article-title":"Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management","volume":"92","author":"Vose","year":"2017","journal-title":"Am J Hematol"},{"issue":"9 September","key":"10.1053\/j.semdp.2021.03.006_bib0029","first-page":"1","article-title":"Mantle cell lymphoma with gastrointestinal involvement and the role of endoscopic examinations","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1053\/j.semdp.2021.03.006_bib0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000496508","article-title":"Gastrointestinal involvement in patients with mantle cell lymphoma: a single center experience of eighty-five patients","volume":"37","author":"Lamm","year":"2019","journal-title":"Dig Dis"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0031","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1097\/HS9.0000000000000302","article-title":"Mantle cell lymphoma of mucosa-associated lymphoid tissue: a European mantle cell lymphoma network study","volume":"4","author":"Morello","year":"2020","journal-title":"HemaSphere"},{"key":"10.1053\/j.semdp.2021.03.006_bib0032","first-page":"10","article-title":"Mantle cell lymphoma: a rare cause of a solitary duodenal mass","author":"Moussaide","year":"2014","journal-title":"BMJ Case Rep. Published online"},{"key":"10.1053\/j.semdp.2021.03.006_bib0033","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.anndiagpath.2016.09.016","article-title":"Expression of LEF1 in mantle cell lymphoma","volume":"26","author":"O'Malley","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0034","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/modpathol.2017.135","article-title":"CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course","volume":"31","author":"Hu","year":"2018","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2021.03.006_bib0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00428-020-02772-1","article-title":"Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas","volume":"476","author":"Montes-Moreno","year":"2020","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0036","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/bjh.12854","article-title":"SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study","volume":"166","author":"Nordstr\u00f6m","year":"2014","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.semdp.2021.03.006_bib0037","first-page":"699","article-title":"Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma","volume":"36","author":"Stefancikova","year":"2010","journal-title":"Int J Oncol"},{"issue":"5","key":"10.1053\/j.semdp.2021.03.006_bib0038","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bjh.17023","article-title":"p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma","volume":"191","author":"Rodrigues","year":"2020","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0039","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood-2017-07-797019","article-title":"Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network","volume":"131","author":"Aukema","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-020-02750-7","article-title":"Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11","volume":"477","author":"Croci","year":"2020","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0041","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","article-title":"Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL network","volume":"2","author":"Klapper","year":"2009","journal-title":"J Hematop"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0042","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2007-10-117010","article-title":"Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group","volume":"111","author":"Determann","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.semdp.2021.03.006_bib0043","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.5858\/arpa.2018-0275-RA","article-title":"Update on gastrointestinal lymphomas","volume":"142","author":"Weindorf","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0044","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3748\/wjg.v22.i4.1674","article-title":"Diagnosis of follicular lymphoma of the gastrointestinal tract: a better initial diagnostic workup","volume":"22","author":"Iwamuro","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1053\/j.semdp.2021.03.006_bib0045","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/cas.13031","article-title":"CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine","volume":"107","author":"Ohnishi","year":"2016","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1053\/j.semdp.2021.03.006_bib0046","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/bjh.16348","article-title":"What do we know about duodenal-type follicular lymphoma? From pathological definition to treatment options","volume":"188","author":"Duffles Amarante","year":"2020","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.semdp.2021.03.006_bib0047","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/PAS.0b013e318224e661","article-title":"Primary follicular lymphoma of the gastrointestinal tract","volume":"35","author":"Misdraji","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2021.03.006_bib0048","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","article-title":"Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases","volume":"29","author":"Schmatz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pin.12621","article-title":"Gastrointestinal follicular lymphoma: current knowledge and future challenges","volume":"68","author":"Takata","year":"2018","journal-title":"Pathol Int"},{"issue":"16","key":"10.1053\/j.semdp.2021.03.006_bib0050","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2021.03.006_bib0051","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0016-5085(91)90063-Q","article-title":"Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients","volume":"101","author":"Cogliatti","year":"1991","journal-title":"Gastroenterology"},{"issue":"31","key":"10.1053\/j.semdp.2021.03.006_bib0052","article-title":"Clinical characteristics and prognostic factors of primary gastric lymphoma: a retrospective study with 165 cases","volume":"95","author":"Wang","year":"2016","journal-title":"Med (United States)"},{"issue":"21","key":"10.1053\/j.semdp.2021.03.006_bib0053","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1182\/blood-2012-01-404194","article-title":"Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas","volume":"119","author":"Kuo","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.semdp.2021.03.006_bib0054","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1200\/JCO.2001.19.7.2041","article-title":"Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection","volume":"19","author":"Morgner","year":"2001","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.semdp.2021.03.006_bib0055","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/00000478-200012000-00008","article-title":"Histologic and immunohistologic findings and prognosis of 40 cases of gastric large B-cell lymphoma","volume":"24","author":"Takeshita","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0056","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0609.2006.00709.x","article-title":"Prognostic factor analysis and proposed prognostic model for conventional treatment of high-grade primary gastric lymphoma","volume":"77","author":"Park","year":"2006","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1053\/j.semdp.2021.03.006_bib0057","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2036.2006.02826.x","article-title":"Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study","volume":"23","author":"Andriani","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1053\/j.semdp.2021.03.006_bib0058","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1002\/cam4.1595","article-title":"A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B-cell lymphoma in the rituximab era","volume":"7","author":"Ishikawa","year":"2018","journal-title":"Cancer Med"},{"key":"10.1053\/j.semdp.2021.03.006_bib0059","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3389\/fonc.2020.01093","article-title":"Nomogram for predicting the overall survival of adult patients with primary gastrointestinal diffuse large B cell lymphoma: a SEER- based study","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"10","key":"10.1053\/j.semdp.2021.03.006_bib0060","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.5858\/arpa.2011-0145-RA","article-title":"Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis","volume":"135","author":"Burke","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0061","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2559.2008.03140.x","article-title":"Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma","volume":"53","author":"Chuang","year":"2008","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2021.03.006_bib0062","article-title":"B-Cell Lymphomas (Version 1.2021)","year":"2021","journal-title":"NCCN Clin Pract Guidelines Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0063","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.semdp.2021.03.006_bib0064","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2006-05-022517","article-title":"High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2021.03.006_bib0065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2559.2007.02855.x","article-title":"Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different. An immunohistochemical and clinical study","volume":"51","author":"Connor","year":"2007","journal-title":"Histopathology"},{"issue":"9","key":"10.1053\/j.semdp.2021.03.006_bib0066","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1080\/10428190802238552","article-title":"Differences in germinal centre and non-germinal center phenotype in gastric and intestinal diffuse large B-cell lymphomas","volume":"49","author":"Mitchell","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2021.03.006_bib0067","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.humpath.2019.09.003","article-title":"Colorectal diffuse large B-cell lymphoma: molecular subclassification and prognostic significance of immunoglobulin gene translocation","volume":"96","author":"Hori","year":"2020","journal-title":"Hum Pathol"},{"issue":"6769","key":"10.1053\/j.semdp.2021.03.006_bib0068","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0069","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.leukres.2011.12.012","article-title":"The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"36","author":"Castillo","year":"2012","journal-title":"Leuk Res"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/00365520510024205","article-title":"Cytogenetic and clinicopathological characterization by fluorescence in situ hybridization on paraffin-embedded tissue sections of twenty-six cases with malignant lymphoma of small intestine","volume":"41","author":"Yoshida","year":"2006","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1053\/j.semdp.2021.03.006_bib0071","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/PAS.0000000000001577","article-title":"High-grade B-Cell Lymphoma with MYC, BCL2, and\/or BCL6 Translocations\/Rearrangements: clinicopathologic Features of 51 Cases in a Single Institution of South China","volume":"44","author":"Zhang","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2021.03.006_bib0072","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"10.1053\/j.semdp.2021.03.006_bib0073","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0074","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5045\/br.2020.55.1.49","article-title":"HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases","volume":"55","author":"Li","year":"2020","journal-title":"Blood Res"},{"key":"10.1053\/j.semdp.2021.03.006_bib0075","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.5858\/arpa.2016-0232-RA","article-title":"Plasmablastic lymphoma a review of clinicopathologic features and differential diagnosis","volume":"140","author":"Harmon","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1053\/j.semdp.2021.03.006_bib0076","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2021.03.006_bib0077","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2021.03.006_bib0078","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/ajh.25955","article-title":"Survival analysis in treated plasmablastic lymphoma patients: a population-based study","volume":"95","author":"Florindez","year":"2020","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0079","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.clml.2018.10.003","article-title":"Epstein-Barr Virus\u2013Positive Mucocutaneous Ulcer: case Report and Review of the First 100 Published Cases","volume":"19","author":"Sinit","year":"2019","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"issue":"11","key":"10.1053\/j.semdp.2021.03.006_bib0080","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive Mucocutaneous ulcer in organ transplant recipients a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0081","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000001186","article-title":"The spectrum of EBV-positive mucocutaneous ulcer","volume":"43","author":"Prieto-Torres","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0082","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3960\/jslrt.18039","article-title":"A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects","volume":"59","author":"Ikeda","year":"2019","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"10.1053\/j.semdp.2021.03.006_bib0083","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer-A study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"9506","key":"10.1053\/j.semdp.2021.03.006_bib0084","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":"Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.semdp.2021.03.006_bib0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/ejh.13226","article-title":"Frequency, characteristics, and outcome of PTLD after allo-SCT: a multicenter study from the Spanish group of blood and marrow transplantation (GETH)","volume":"102","author":"Garc\u00eda-Cadenas","year":"2019","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1053\/j.semdp.2021.03.006_bib0086","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.healun.2011.10.013","article-title":"Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases","volume":"31","author":"Kremer","year":"2012","journal-title":"J Hear Lung Transplant"},{"issue":"3","key":"10.1053\/j.semdp.2021.03.006_bib0087","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1053\/j.semdp.2021.03.006_bib0088","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/10428194.2018.1474462","article-title":"Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation","volume":"60","author":"Romero","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"1052","key":"10.1053\/j.semdp.2021.03.006_bib0089","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140861","article-title":"Is there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients","volume":"88","author":"Tai","year":"2015","journal-title":"Br J Radiol"},{"issue":"17","key":"10.1053\/j.semdp.2021.03.006_bib0090","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA - J Am Med Assoc"},{"issue":"6","key":"10.1053\/j.semdp.2021.03.006_bib0091","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.semdp.2021.03.006_bib0092","first-page":"458","article-title":"Posttransplantation lymphoproliferative disorder: endoscopic findings","volume":"31","author":"O\u2019Connor","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0093","first-page":"248","article-title":"Post-transplantation lymphoproliferative disorder with gastrointestinal involvement","volume":"31","author":"Inayat","year":"2018","journal-title":"Ann Gastroenterol"},{"issue":"9","key":"10.1053\/j.semdp.2021.03.006_bib0094","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1053\/j.semdp.2021.03.006_bib0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: sixth European conference on infections in leukemia (ECIL-6) guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.semdp.2021.03.006_bib0096","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3109\/10428194.2013.780655","article-title":"Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors","volume":"54","author":"Dierickx","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.semdp.2021.03.006_bib0097","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/1319-2442.132201","article-title":"Colorectal involvement by post-transplant lymphoproliferative disorders: a review of 81 cases","volume":"25","author":"Khedmat","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"10.1053\/j.semdp.2021.03.006_bib0098","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4103\/1319-2442.128543","article-title":"Localization of post-transplant lymphoproliferative disorders to the stomach might be associated with favorable outcome: a systematic review","volume":"25","author":"Ghamar-Chehreh","year":"2014","journal-title":"Saudi J Kidney Dis Transplant"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257021000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:21:39Z","timestamp":1760037699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257021000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0740257021000162"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2021.03.006","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on B-cell lymphoproliferative disorders of the gastrointestinal tract","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}